ResApp Health Limited (RAP) 2018年年度报告「ASX」.pdf

1、 1 ResApp Health Limited ABN 51 094 468 318 CONSOLIDATED ANNUAL REPORT FOR THE YEAR ENDED 30 JUNE 2018ResApp Health Limited Consolidated Annual Report ABN 51 094 468 318 Contents to the Consolidated Financial Report 2 Corporate Information.3 Directors Report.4 Auditors Independence Declaration.16 Co

2、nsolidated Statement of Profit and Loss and Other Comprehensive Income .17 Consolidated Statement of Financial Position.18 Consolidated Statement of Changes in Equity.19 Consolidated Statement of Cash Flows.20 Notes to the Consolidated Financial Statements.21 Directors Declaration.42 Independent Aud

3、itors Report.43 ASX Additional Information.47 ResApp Health Limited Consolidated Annual Report ABN 51 094 468 318 Corporate Information 3 This annual report is for ResApp Health Limited and its controlled entity(“the Group”).Unless otherwise stated,all amounts are presented in Australian Dollars.A d

4、escription of the Groups operations and of its principal activities is included in the review of operations and activities in the directors report on pages 7-11.The directors report is not part of the financial statements.Directors Dr Roger Aston(appointed 2 July 2015)Dr Tony Keating(appointed 2 Jul

5、y 2015)Mr Chris Ntoumenopoulos(appointed 21 January 2015)Mr Nathan Buzza(appointed 28 December 2017)Company Secretary Ms Nicki Farley Principal Office Level 8,127 Creek St Brisbane QLD 4000 Registered Office Auditors Level 24 Grant Thornton Audit Pty Ltd 44 St Georges Tce,Level 43,152-158 St Georges

6、 Terrace PERTH WA 6000 PERTH WA 6000 Share Registry&Register Solicitors Link Market Services Ltd Price Sierakowski Corporate Level 12,250 St Georges Tce Level 24,44 St Georges Tce PERTH WA 6000 PERTH WA 6000 Bankers Stock Exchange Listing National Australia Bank ResApp Health Limited 100 St Georges